Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Antengene's ATG-022 (CLDN18.2 ADC) Granted Breakthrough Therapy Designation for the Treatment of Gastric/Gastroesophageal Junction Adenocarcinoma 2025-08-19 13:26
Beyfortus® (nirsevimab) approved in Singapore to protect all infants against RSV disease 2025-08-19 11:00
RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries 2025-08-19 08:00
Avixgen, a subsidiary of Dx&Vx, signs a licensing-out agreement worth USD 360 million with a U.S. biotech company for its next-generation drug delivery platform (ACP). 2025-08-18 21:00
KELUN-BIOTECH ANNOUNCES 2025 INTERIM RESULTS 2025-08-18 18:29
New support group to provide social and community support for neurofibromatosis patients 2025-08-18 09:00
Etrasimod Receives Strong Recommendation in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults for Induction and Maintenance Phase of Moderately to Severely Active UC 2025-08-15 09:35
TraceLink Accelerates Supply Chain Transformation with New OPUS Platform Capabilities for an AI-Powered Future 2025-08-14 22:00
Leads Biolabs Announces Completion of Patient Enrollment in Pivotal Trial of Opamtistomig Monotherapy for Extrapulmonary Neuroendocrine Carcinoma 2025-08-14 17:38
Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY® by the Taiwan Food and Drug Administration for the Treatment of Moderately to Severely Active Ulcerative Colitis 2025-08-14 12:02
Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD Therapy Worldwide 2025-08-14 08:00
Telitacicept Meets Primary Endpoint in Phase III Trial for Primary Sjögren's Syndrome in China 2025-08-13 17:57
Prince Court Medical Centre Strengthens Malaysia's Position as a Global Healthcare Destination with First Kelly Procedure 2025-08-13 15:16
WuXi Biologics' WuXiUP™ Accomplishes Automated Continuous Drug Substance Production at Pilot-Scale 2025-08-12 17:00
Intas & Accord signs Agreement to acquire Prothya Biosolutions 2025-08-11 21:41
Everest Medicines to Announce 2025 Interim Results on August 29, 2025 2025-08-11 17:11
Philippines' AC Health partners with Singapore's ABC Impact in vision to transform health for every Filipino 2025-08-11 10:31
RemeGen's Independently-Developed Bispecific Antibody RC148 Approved to Proceed Phase II Clinical Trial in US by FDA 2025-08-08 17:50
Codex Genetics Expands Precision Oncology Portfolio with Cxbladder Genomic Urine Tests 2025-08-08 17:45
WCC Biomedical@NACDS Total Store Expo: Advancing Microneedle Drug Delivery With WINMAP™ Platform 2025-08-08 09:30
1 10 11 12 13 14 280